DEPLOYDatabase

Robot model

Connexus BCI

biometricpilotby Paradromics

Fully implantable high data-rate brain-computer interface designed to restore speech and computer control for severely motor-impaired patients.

Track Connexus BCI
Manufacturer
Paradromics
Form factor
biometric
Maturity
pilot
Lifecycle
active
Deployments
2
Website
paradromics.com ↗

Deploy Watch

Track Connexus BCI on Deploy.

We notify you when a verified state change lands on the record, not when the company issues a claim.

Track Connexus BCI

Key facts

FDA IDE (company-stated, Nov 2025)

FDA granted IDE approval for the Connect-One early feasibility study of Connexus for speech restoration and computer control in severe motor impairment.

Study registry (ClinicalTrials.gov)

NCT07357428: interventional, sponsored by Paradromics, recruiting, estimated enrollment of 2, across UC Davis, Massachusetts General Hospital and Univ. of Michigan.

First implant (company-stated, Jun 2026)

Done at University of Michigan Health by Matthew Willsey, M.D., Ph.D., with Aditya S. Pandey, M.D., for a participant with motor neuron disease.

Follow-up (company-stated)

Planned six-year follow-up for the first implant participant.

Data & sources

Web sources

3

3 sources backing this record.View all →

Pricing

No verified price is on record for Connexus BCI. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.

How DEPLOY tracks pricing

Deployments (2)

Connexus BCI on the deployment map

View the global map

Where Connexus BCI is verified operating. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Full change history →

Safety record

No incidents on record for Connexus BCI.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Sources (3)

  1. https://paradromics.com/news/paradromics-receives-fda-approval-for-the-connect-one-clinical-study-with-the-connexus-brain-computer-interface/
  2. https://paradromics.com/news/paradromics-completes-first-human-brain-computer-interface-bci-implantation/
  3. https://clinicaltrials.gov/study/NCT07357428

Mentioned on (1)

Registry pages whose text names Connexus BCI.

Companies (1)

Paradromics

Common questions

What is Connexus BCI?
Fully implantable high data-rate brain-computer interface designed to restore speech and computer control for severely motor-impaired patients.
How much does Connexus BCI cost?
Connexus BCI's price is not publicly disclosed. DEPLOY has no verified price on record for Connexus BCI from Paradromics. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
Is Connexus BCI actually deployed in the real world?
Yes. Connexus BCI is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
Who makes Connexus BCI?
Connexus BCI is made by Paradromics, based in Austin, Texas, USA.
Where is Connexus BCI deployed?
2 verified deployments of Connexus BCI are on the DEPLOY registry, including at Germany, Europe, United States.
Can you buy Connexus BCI?
Connexus BCI is in pilot deployments with named customers and is not yet broadly for sale.
What are alternatives to Connexus BCI?
On the DEPLOY registry, comparable biometric robots to Connexus BCI include Blackrock Neuroport Array, Synchron Stentrode, BrainQ Non-Invasive BCI, Neko Body Scan.
How does Connexus BCI compare to Blackrock Neuroport Array?
Connexus BCI and Blackrock Neuroport Array (Blackrock Neurotech · 5 deployments) are both biometric robots on the DEPLOY registry. Connexus BCI has 2 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
Is Connexus BCI a top biometric?
On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Connexus BCI ranks in roughly the top 58% of biometric models tracked by the registry.
What is Connexus BCI's maturity stage?
Connexus BCI is at the pilot stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Pilot stage means at least one named-customer trial deployment is verified.
Is Connexus BCI safe?
Connexus BCI has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 3 sources (no primary) · last reviewed 2026-10-10

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-10-10

Maturity + lifecycle

Maturity stage: pilot

Lifecycle: active

Architectural position

Cohort: biometric

Sources by quality tier

3
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for Connexus BCI.

Recent coverage

Connexus BCI in third-party press

Paradromics and University of Michigan complete first Connexus BCI implantation in clinical study

Jun 18, 2026